Belgian biopharma co UCB cancels Teva deal
Globes - 55 minutes ago
UCB said that Teva will undertake full commercial responsibility for the marketing of its ProAir asthma inhaler. Belgian biopharmaceutical company UCB SA (Euronext: UCB) plans to accelerate its US ...
http://digg.com/u1LqRw
No comments:
Post a Comment